Đang chuẩn bị liên kết để tải về tài liệu:
Final analysis of the phase 3 randomized clinical trial comparing HD201 vs. referent trastuzumab in patients with ERBB2-positive breast cancer treated in the neoadjuvant setting

Đang chuẩn bị nút TẢI XUỐNG, xin hãy chờ

The TROIKA trial established that HD201 and trastuzumab were equivalent in terms of primary end-points (total pathological complete response) following neoadjuvant treatment. The objective of the present analysis was to compare survival outcomes and final safety. |

TÀI LIỆU LIÊN QUAN

GnRH agonist for final oocyte maturation in GnRH antagonist co-treated IVF/ICSI treatment cycles: Systematic review and meta-analysis

Tutorial Final and Construction Stage Analysis for a Cable-Stayed Bridge

Final exam course Power system analysis - ĐH Bách khoa TP.HCM

The Relationship Between Final Consumption and Economic Sectors – A Structural Path Analysis Approach

Advanced Application 2- Final and Construction Stage Analysis for a Cable - Stayed Bridge

The Economics of Taxation

Environmental Impact of Products (EIPRO) Analysis of the life cycle environmental impacts related to the final consumption of the EU-25

ADOPTION OF THE FINAL ACT AND ANY INSTRUMENTS, RECOMMENDATIONS AND RESOLUTIONS RESULTING FROM THE WORK OF THE CONFERENCE

The Last Leaf by O.Henry

Synthesis and characterization of feed grade monocalcium phosphate, Ca(h2po4)2·H2O in aqueous medium